Industry

Organigram
Industry

Canadian Province Has Ordered Almost 10 Million Grams Of Cannabis

Moncton-based medical cannabis producer, Organigram, will provide New Brunswick with at least five million grams a year to supply the recreational market.

Sep 18, 2017 - Lukas W

Organigram, the large-scale Moncton-based medical cannabis producer, says it will provide New Brunswick with at least five million grams a year to supply the recreational market. While Canopy Growth Corporation based out of Smith Falls, Ontario signed a two-year agreement with the province, allowing the supply of another 4 million grams of cannabis and extract-related products.

Small province with a large demand

Almost 10 Million 1 Cops Advertised For Weed In This School Newsletter
Photo credit

New Brunswick Finance Minister Cathy Rogers and Health Minister Benoît Bourque made the announcement on Friday in Moncton. The province has already inked deals with two licensed medical cannabis producers to help supply its recreational market. The two contracts can provide up to $100 million worth of cannabis annually, allowing for a large influx of new customers come federal legalization.

These are the first agreements that any province has signed for supply from licensed producers in Canada. Part of the initiative to get this supply agreement in place was they understand that there will be a supply deficiency for the first couple years of the adult recreational market, and they wanted to make sure that they were in a position to get a significant supply going forward and be the first to do so. – Greg Engel, Organigram CEO

Both producers are justifiably excited for the future with one of Canada’s smaller province and hope that a deal of this magnitude can be repeated as other provinces figure out their cannabis frameworks in the coming months.

New Brunswick has led the country in its efforts to attract cannabis jobs and investment and Canopy Growth is proud to be utilizing local trades and to hire in New Brunswick for the site we are establishing in Fredericton. – Mark Zekulin, president of Canopy Growth

As news broke of the pending deal with the provincial government, stocks of both Canopy and Organigram climbed on Friday, closing up by 2.09 percent and 16.74 percent, respectively.

Friday’s New Brunswick news followed that of the Ontario government, which plans on creating a single legal entity for cannabis, with sales overseen by the province’s liquor control board(LCBO). The retailer would sell recreational cannabis through 150 dispensaries and an e-commerce site.

Ontario, however, has not struck a supply deal, a government spokesperson told the Financial Post.You can check out the full story on Ontario’s retail plan here.


Share This

Related Articles

Experts predict the country won’t come close to being able to supply the new legal market.

Canada Isn’t Licensing Cannabis Cultivation Sites Fast Enough To Meet Demand

Constellation Brands has already poured $200 million into the Canadian cannabis industry. Now, it’s looking to invest another $5 billion.

Bruce Linton, chief executive officer of Canopy Growth Corp., stands for a photograph in the Mother Room at the Canopy Growth Corp. facility in Smith Falls, Ontario, Canada, on Tuesday, Dec. 19, 2017. Canadian medical marijuana is setting the stage to go global. Canopy received $200 million from Constellation Brands last year. Now, the makers of Corona are looking to give the licensed producer another $5 billion.

Cannabis reform is slowly but surely happening on the continent.

Canadian Cultivator Aphria Bets On A Future African Cannabis Market

Comments

Stay in the loop

Exclusive deals, original content.
Delivered to you.